Article Image
News Link • Science, Medicine and Technology

MS Breakthrough

• arclein
However, during a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body’s attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: